RUNX1 expression has been shown to be regulated by AR in human prostate cancer and triple negative breast cancer cells in vitro [46, 47] and ReMap ChIP-seq data reveals AR binding sites on mouse Runx1 and -2 promoter and intronic areas. This evidence concerns the gene AR and prostate carcinoma.